Physician profile
Emad Adnan Kowatli
NPI 1447257787
$5,706.69
in general payments reported to CMS, 2019-2025
28 companies · $2,093 in 2025
The $2,093 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $813 · 2023: $1,100 · 2024: $1,700 · 2025: $2,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,577 · Education: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,577.39 |
| Education | $316.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,177.68 | 2022-2025 | Fasenra, Breztri, Tezspire |
| Jazz Pharmaceuticals INC. | $1,082.05 | 2022-2025 | |
| Glaxosmithkline, LLC. | $622.82 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Harmony Biosciences LLC | $367.49 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $259.71 | 2023-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $254.75 | 2022-2025 | Ofev, Jascayd |
| Philips North America LLC | $232.75 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Mylan Specialty L.P. | $200.84 | 2023-2024 | Yupelri |
| Axsome Therapeutics, INC. | $176.64 | 2023-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $151.49 | 2023-2024 | Glassia |
| Insmed, INC. | $145.82 | 2024-2025 | Arikayce, Brinsupri |
| Inspire Medical Systems, INC. | $144.14 | 2023-2025 | Inspire |
| Vifor Pharma, INC. | $125.58 | 2024-2025 | Zemaira |
| Merck Sharp & Dohme LLC | $108.02 | 2024-2025 | Keytruda, Capvaxive |
| Janssen Pharmaceuticals, INC | $97.04 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $90.98 | 2025 | Ohtuvayre |
| Baxter Healthcare | $87.30 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $84.05 | 2023-2025 | Tezspire |
| Resmed Corp | $54.09 | 2024 | |
| Viatris Specialty LLC | $44.44 | 2025 | Yupelri |
| Inogen, INC. | $42.49 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Paratek Pharmaceuticals, INC. | $35.22 | 2024 | Nuzyra |
| Genzyme Corporation | $33.40 | 2024-2025 | |
| Fisher & Paykel Healthcare INC | $21.66 | 2023 | Fisher & Paykel Healthcare |
| Lilly USA, LLC | $19.47 | 2025 | Zepbound |
| Optinose US, INC. | $17.70 | 2024 | |
| Dexcom, INC. | $16.55 | 2023 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emad Kowatli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.